Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1991 May-Jun;64(3):247–254.

Pseudohypoaldosteronism: case report and discussion of the syndrome.

D C Throckmorton 1, M J Bia 1
PMCID: PMC2589321  PMID: 1788991

Abstract

A 41-year-old man, complaining of leg cramps, was found to have persistent hyperkalemia. Except for mild hypertension, his physical examination and laboratory values to exclude connective tissue diseases and diabetes mellitus were normal. Renal function testing revealed a normal glomerular filtration rate and tubular capacity to acidify and dilute, as well as near-normal ability to concentrate his urine. Hormonal evaluation revealed a normal cortisol, as well as normal resting and stimulated renin and aldosterone levels. A selective defect in tubular potassium secretion was demonstrated. In the absence of aldosterone deficiency or renal dysfunction, it was assumed that the patient had primary renal resistance to aldosterone, known as pseudohypoaldosteronism. Treatment with hydrochlorothiazide controlled his hyperkalemia and hypertension. His case emphasizes the diagnostic and therapeutic factors that should be considered in evaluating and treating a non-hospitalized patient with sustained hyperkalemia.

Full text

PDF
247

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armanini D., Kuhnle U., Strasser T., Dorr H., Butenandt I., Weber P. C., Stockigt J. R., Pearce P., Funder J. W. Aldosterone-receptor deficiency in pseudohypoaldosteronism. N Engl J Med. 1985 Nov 7;313(19):1178–1181. doi: 10.1056/NEJM198511073131902. [DOI] [PubMed] [Google Scholar]
  2. Arnold J. E., Healy J. K. Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med. 1969 Sep;47(3):461–472. doi: 10.1016/0002-9343(69)90230-7. [DOI] [PubMed] [Google Scholar]
  3. Arruda J. A., Batlle D. C., Sehy J. T., Roseman M. K., Baronowski R. L., Kurtzman N. A. Hyperkalemia and renal insufficiency: role of selective aldosterone deficiency and tubular unresponsiveness to aldosterone. Am J Nephrol. 1981;1(3-4):160–167. doi: 10.1159/000166533. [DOI] [PubMed] [Google Scholar]
  4. Bosson D., Kuhnle U., Mees N., Ramet J., Vamos E., Vertongen F., Wolter R., Armanini D. Generalized unresponsiveness to mineralocorticoid hormones: familial recessive pseudohypoaldosteronism due to aldosterone-receptor deficiency. Acta Endocrinol Suppl (Copenh) 1986;279:376–380. doi: 10.1530/acta.0.112s376. [DOI] [PubMed] [Google Scholar]
  5. Brautbar N., Levi J., Rosler A., Leitesdorf E., Djaldeti M., Epstein M., Kleeman C. R. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling. Arch Intern Med. 1978 Apr;138(4):607–610. [PubMed] [Google Scholar]
  6. CHEEK D. B., PERRY J. W. A salt wasting syndrome in infancy. Arch Dis Child. 1958 Jun;33(169):252–256. doi: 10.1136/adc.33.169.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Claris Appiani A., Marra G., Tirelli S. A., Goj V., Romeo L., Cavanna G., Assael B. M. Early childhood hyperkalemia: variety of pseudohypoaldosteronism. Acta Paediatr Scand. 1986 Nov;75(6):970–974. doi: 10.1111/j.1651-2227.1986.tb10325.x. [DOI] [PubMed] [Google Scholar]
  8. DONNELL G. N., LITMAN N., ROLDAN M. Pseudohypo-adrenalocorticism; renal sodium loss, hyponatremia, and hyperkalemia due to a renal tubular insensitivity to mineralocorticoids. AMA J Dis Child. 1959 Jun;97(6):813–828. [PubMed] [Google Scholar]
  9. David R., Golan S., Drucker W. Familial aldosterone deficiency: enzyme defect, diagnosis, and clinical course. Pediatrics. 1968 Feb;41(2):403–412. [PubMed] [Google Scholar]
  10. DeFronzo R. A. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980 Jan;17(1):118–134. doi: 10.1038/ki.1980.14. [DOI] [PubMed] [Google Scholar]
  11. Ethier J. H., Kamel K. S., Magner P. O., Lemann J., Jr, Halperin M. L. The transtubular potassium concentration in patients with hypokalemia and hyperkalemia. Am J Kidney Dis. 1990 Apr;15(4):309–315. doi: 10.1016/s0272-6386(12)80076-x. [DOI] [PubMed] [Google Scholar]
  12. Farfel Z., Iaina A., Rosenthal T., Waks U., Shibolet S., Gafni J. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect. Arch Intern Med. 1978 Dec;138(12):1828–1832. [PubMed] [Google Scholar]
  13. Gordon R. D., Geddes R. A., Pawsey C. G., O'Halloran M. W. Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med. 1970 Nov;19(4):287–294. doi: 10.1111/imj.1970.19.4.287. [DOI] [PubMed] [Google Scholar]
  14. Kuhnle U., Nielsen M. D., Tietze H. U., Schroeter C. H., Schlamp D., Bosson D., Knorr D., Armanini D. Pseudohypoaldosteronism in eight families: different forms of inheritance are evidence for various genetic defects. J Clin Endocrinol Metab. 1990 Mar;70(3):638–641. doi: 10.1210/jcem-70-3-638. [DOI] [PubMed] [Google Scholar]
  15. Nahum H., Paillard M., Prigent A., Leviel F., Bichara M., Gardin J. P., Idatte J. M. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia. Am J Nephrol. 1986;6(4):253–262. doi: 10.1159/000167172. [DOI] [PubMed] [Google Scholar]
  16. Popovtzer M. M., Katz F. H., Pinggera W. F., Robinette J., Halgrimson C. G., Butkus D. E. Hyperkalemia in salt-wasting nephropathy. Study of the mechanism. Arch Intern Med. 1973 Aug;132(2):203–208. [PubMed] [Google Scholar]
  17. Popow C., Pollak A., Herkner K., Scheibenreiter S., Swoboda W. Familial pseudohypoaldosteronism. Acta Paediatr Scand. 1988 Jan;77(1):136–141. doi: 10.1111/j.1651-2227.1988.tb10612.x. [DOI] [PubMed] [Google Scholar]
  18. Postel-Vinay M. C., Alberti G. M., Ricour C., Limal J. M., Rappaport R., Royer P. Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone. J Clin Endocrinol Metab. 1974 Dec;39(6):1038–1044. doi: 10.1210/jcem-39-6-1038. [DOI] [PubMed] [Google Scholar]
  19. RAINE D. N., ROY J. A salt-losing syndrome in infancy. Pseudo-hypoadrenocorticalism. Arch Dis Child. 1962 Oct;37:548–556. doi: 10.1136/adc.37.195.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rösler A., Theodor R., Boichis H., Gerty R., Ulick S., Alagem M., Tabachinik E., Cohen B., Rabinowitz D. Metabolic responses to the administration of angiotensin II, K and ACTH in two salt-wasting syndromes. J Clin Endocrinol Metab. 1977 Feb;44(2):292–301. doi: 10.1210/jcem-44-2-292. [DOI] [PubMed] [Google Scholar]
  21. Rösler A., Theodor R., Gazit E., Biochis H., Rabinowitz D. Salt wasting, raised plasma-renin activity, and normal or high plasma-aldosterone: a form of pseudohypoaldosteronism. Lancet. 1973 May 5;1(7810):959–962. doi: 10.1016/s0140-6736(73)91599-7. [DOI] [PubMed] [Google Scholar]
  22. Schambelan M., Sebastian A., Rector F. C., Jr Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption. Kidney Int. 1981 May;19(5):716–727. doi: 10.1038/ki.1981.72. [DOI] [PubMed] [Google Scholar]
  23. Stokes G. S., Gentle J. L., Edwards K. D., Stewart J. H. Syndrome of idiopathic hyperkalaemia and hypertension with decreased plasma renin activity: effects on plasma renin and aldosterone of reducing the serum potassium level. Med J Aust. 1968 Dec 7;2(23):1050–1054. doi: 10.5694/j.1326-5377.1968.tb83401.x. [DOI] [PubMed] [Google Scholar]
  24. Wayne V. S., Stockigt J. R., Jennings G. L. Treatment of mineralocorticoid-resistant renal hyperkalemia with hypertension (type II pseudohypoaldosteronism). Aust N Z J Med. 1986 Apr;16(2):221–223. doi: 10.1111/j.1445-5994.1986.tb01154.x. [DOI] [PubMed] [Google Scholar]
  25. Wehling M., Kuhnle U., Daumer C., Armanini D. Inheritance of mineralocorticoid effector abnormalities of human mononuclear leucocytes in families with pseudohypoaldosteronism. Clin Endocrinol (Oxf) 1989 Nov;31(5):597–605. doi: 10.1111/j.1365-2265.1989.tb01284.x. [DOI] [PubMed] [Google Scholar]
  26. Weinstein S. F., Allan D. M., Mendoza S. A. Hyperkalemia, acidosis, and short stature associated with a defect in renal potassium excretion. J Pediatr. 1974 Sep;85(3):355–358. doi: 10.1016/s0022-3476(74)80115-0. [DOI] [PubMed] [Google Scholar]
  27. Werder E. A., Hilbe W., Vallotton M. B. Prostaglandin excretion in pseudohypoaldosteronism type I. Acta Endocrinol Suppl (Copenh) 1986;279:381–385. doi: 10.1530/acta.0.112s381. [DOI] [PubMed] [Google Scholar]
  28. West M. L., Bendz O., Chen C. B., Singer G. G., Richardson R. M., Sonnenberg H., Halperin M. L. Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab. 1986;12(4):226–233. [PubMed] [Google Scholar]
  29. West M. L., Marsden P. A., Richardson R. M., Zettle R. M., Halperin M. L. New clinical approach to evaluate disorders of potassium excretion. Miner Electrolyte Metab. 1986;12(4):234–238. [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES